US Stock MarketDetailed Quotes

ANIX Anixa Biosciences

Watchlist

3.230
+0.250+8.39%

Close Apr 26 16:00 ET

3.300
+0.070+2.17%

Post 19:59 ET

103.04MMarket Cap-9500P/E (TTM)

Anixa Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jan 31, 2024

(FY)Oct 31, 2023

(Q4)Oct 31, 2023

(Q3)Jul 31, 2023

(Q2)Apr 30, 2023

(Q1)Jan 31, 2023

(FY)Oct 31, 2022

(Q4)Oct 31, 2022

(Q3)Jul 31, 2022

(Q2)Apr 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-16.15%-2.31M

4.36%-6.21M

-23.60%-1.97M

-3.51%-1.45M

65.00%-807K

-66.08%-1.99M

-31.47%-6.49M

-52.44%-1.59M

5.74%-1.4M

-85.67%-2.31M

Net income from continuing operations

-39.76%-3.29M

27.89%-9.93M

22.90%-2.72M

8.18%-2.55M

35.70%-2.31M

39.31%-2.35M

-4.90%-13.77M

13.31%-3.53M

36.76%-2.78M

-47.23%-3.59M

Depreciation and amortization

18.18%13K

9.52%46K

9.09%12K

10.00%11K

9.09%12K

10.00%11K

-30.00%42K

-31.25%11K

-33.33%10K

-26.67%11K

Other non cash items

43.40%152K

-58.38%313K

-47.01%71K

-45.30%64K

-74.47%72K

-51.60%106K

35.50%752K

0.00%134K

-15.83%117K

64.91%282K

Change In working capital

58.76%-292K

-318.56%-1.06M

-167.87%-488K

-60.26%-125K

155.06%261K

-322.64%-708K

521.79%485K

303.93%719K

73.56%-78K

-470.31%-474K

-Change in receivables

-21.00%-121K

-672.41%-224K

320.69%64K

---79K

---109K

---100K

---29K

--0

-Change in prepaid assets

0.95%212K

-272.60%-775K

-469.79%-710K

-2.03%-351K

-42.42%76K

211.70%210K

-677.78%-208K

23.87%192K

-463.93%-344K

-37.74%132K

-Change in payables and accrued expense

54.09%-370K

-101.97%-15K

-69.96%170K

15.27%317K

151.01%304K

-256.50%-806K

683.51%760K

1,615.15%566K

226.15%275K

-763.77%-596K

-Change in other current liabilities

-8.33%-13K

-21.05%-46K

-20.00%-12K

-33.33%-12K

0.00%-10K

-33.33%-12K

30.91%-38K

0.00%-10K

43.75%-9K

33.33%-10K

Cash from discontinued investing activities

Operating cash flow

-16.15%-2.31M

4.36%-6.21M

-23.60%-1.97M

-3.51%-1.45M

65.00%-807K

-66.08%-1.99M

-31.47%-6.49M

-52.44%-1.59M

5.74%-1.4M

-85.67%-2.31M

Investing cash flow

Cash flow from continuing investing activities

122.05%129K

47.78%-5.6M

94.02%-593K

66.33%-980K

-1,477.60%-3.44M

-131.62%-585K

-173.88%-10.73M

-453.30%-9.92M

-391.10%-2.91M

102.98%250K

Net investment purchase and sale

122.05%129K

47.78%-5.6M

94.02%-593K

66.33%-980K

-1,477.60%-3.44M

-131.62%-585K

-170.98%-10.73M

-454.18%-9.92M

-391.10%-2.91M

102.98%250K

Cash from discontinued investing activities

Investing cash flow

122.05%129K

47.78%-5.6M

94.02%-593K

66.33%-980K

-1,477.60%-3.44M

-131.62%-585K

-173.88%-10.73M

-453.30%-9.92M

-391.10%-2.91M

102.98%250K

Financing cash flow

Cash flow from continuing financing activities

75,333.33%2.26M

-19.03%366K

172.66%279K

-99.64%3K

1,057.14%81K

-98.57%452K

-366.67%-384K

829K

-99.97%7K

Net common stock issuance

--2.2M

----

--0

----

Proceeds from stock option exercised by employees

2,133.33%67K

-19.03%366K

172.66%279K

-99.64%3K

1,057.14%81K

--3K

2.73%452K

-366.67%-384K

--829K

-96.35%7K

Cash from discontinued financing activities

Financing cash flow

75,333.33%2.26M

-19.03%366K

172.66%279K

-99.64%3K

1,057.14%81K

--3K

-98.57%452K

-366.67%-384K

--829K

-99.97%7K

Net cash flow

Beginning cash position

-92.60%915K

-57.57%12.36M

-86.81%3.2M

-79.73%5.62M

-67.13%9.79M

-57.57%12.36M

353.92%29.13M

-10.90%24.25M

0.10%27.73M

148.53%29.78M

Current changes in cash

103.23%83K

31.74%-11.45M

80.81%-2.28M

30.36%-2.42M

-103.51%-4.17M

-493.57%-2.57M

-173.83%-16.77M

-724.03%-11.89M

-623.08%-3.48M

-113.03%-2.05M

End cash Position

-89.81%998K

-92.60%915K

-86.81%3.2M

-79.73%5.62M

-67.13%9.79M

-57.57%12.36M

-10.90%24.25M

0.10%27.73M

Free cash flow

-16.15%-2.31M

4.36%-6.21M

-23.60%-1.97M

-3.51%-1.45M

65.00%-807K

-66.08%-1.99M

-31.47%-6.49M

-52.44%-1.59M

5.74%-1.4M

-85.67%-2.31M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q1)Jan 31, 2024	(FY)Oct 31, 2023	(Q4)Oct 31, 2023	(Q3)Jul 31, 2023	(Q2)Apr 30, 2023	(Q1)Jan 31, 2023	(FY)Oct 31, 2022	(Q4)Oct 31, 2022	(Q3)Jul 31, 2022	(Q2)Apr 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-16.15%-2.31M	4.36%-6.21M	-23.60%-1.97M	-3.51%-1.45M	65.00%-807K	-66.08%-1.99M	-31.47%-6.49M	-52.44%-1.59M	5.74%-1.4M	-85.67%-2.31M
Net income from continuing operations	-39.76%-3.29M	27.89%-9.93M	22.90%-2.72M	8.18%-2.55M	35.70%-2.31M	39.31%-2.35M	-4.90%-13.77M	13.31%-3.53M	36.76%-2.78M	-47.23%-3.59M
Depreciation and amortization	18.18%13K	9.52%46K	9.09%12K	10.00%11K	9.09%12K	10.00%11K	-30.00%42K	-31.25%11K	-33.33%10K	-26.67%11K
Other non cash items	43.40%152K	-58.38%313K	-47.01%71K	-45.30%64K	-74.47%72K	-51.60%106K	35.50%752K	0.00%134K	-15.83%117K	64.91%282K
Change In working capital	58.76%-292K	-318.56%-1.06M	-167.87%-488K	-60.26%-125K	155.06%261K	-322.64%-708K	521.79%485K	303.93%719K	73.56%-78K	-470.31%-474K
-Change in receivables	-21.00%-121K	-672.41%-224K	320.69%64K	---79K	---109K	---100K	---29K	---29K	--0	--0
-Change in prepaid assets	0.95%212K	-272.60%-775K	-469.79%-710K	-2.03%-351K	-42.42%76K	211.70%210K	-677.78%-208K	23.87%192K	-463.93%-344K	-37.74%132K
-Change in payables and accrued expense	54.09%-370K	-101.97%-15K	-69.96%170K	15.27%317K	151.01%304K	-256.50%-806K	683.51%760K	1,615.15%566K	226.15%275K	-763.77%-596K
-Change in other current liabilities	-8.33%-13K	-21.05%-46K	-20.00%-12K	-33.33%-12K	0.00%-10K	-33.33%-12K	30.91%-38K	0.00%-10K	43.75%-9K	33.33%-10K
Cash from discontinued investing activities
Operating cash flow	-16.15%-2.31M	4.36%-6.21M	-23.60%-1.97M	-3.51%-1.45M	65.00%-807K	-66.08%-1.99M	-31.47%-6.49M	-52.44%-1.59M	5.74%-1.4M	-85.67%-2.31M
Investing cash flow
Cash flow from continuing investing activities	122.05%129K	47.78%-5.6M	94.02%-593K	66.33%-980K	-1,477.60%-3.44M	-131.62%-585K	-173.88%-10.73M	-453.30%-9.92M	-391.10%-2.91M	102.98%250K
Net investment purchase and sale	122.05%129K	47.78%-5.6M	94.02%-593K	66.33%-980K	-1,477.60%-3.44M	-131.62%-585K	-170.98%-10.73M	-454.18%-9.92M	-391.10%-2.91M	102.98%250K
Cash from discontinued investing activities
Investing cash flow	122.05%129K	47.78%-5.6M	94.02%-593K	66.33%-980K	-1,477.60%-3.44M	-131.62%-585K	-173.88%-10.73M	-453.30%-9.92M	-391.10%-2.91M	102.98%250K
Financing cash flow
Cash flow from continuing financing activities	75,333.33%2.26M	-19.03%366K	172.66%279K	-99.64%3K	1,057.14%81K	3K	-98.57%452K	-366.67%-384K	829K	-99.97%7K
Net common stock issuance	--2.2M	----	----	----	----	--0	----	----	----	----
Proceeds from stock option exercised by employees	2,133.33%67K	-19.03%366K	172.66%279K	-99.64%3K	1,057.14%81K	--3K	2.73%452K	-366.67%-384K	--829K	-96.35%7K
Cash from discontinued financing activities
Financing cash flow	75,333.33%2.26M	-19.03%366K	172.66%279K	-99.64%3K	1,057.14%81K	--3K	-98.57%452K	-366.67%-384K	--829K	-99.97%7K
Net cash flow
Beginning cash position	-92.60%915K	-57.57%12.36M	-86.81%3.2M	-79.73%5.62M	-67.13%9.79M	-57.57%12.36M	353.92%29.13M	-10.90%24.25M	0.10%27.73M	148.53%29.78M
Current changes in cash	103.23%83K	31.74%-11.45M	80.81%-2.28M	30.36%-2.42M	-103.51%-4.17M	-493.57%-2.57M	-173.83%-16.77M	-724.03%-11.89M	-623.08%-3.48M	-113.03%-2.05M
End cash Position	-89.81%998K	-92.60%915K	-92.60%915K	-86.81%3.2M	-79.73%5.62M	-67.13%9.79M	-57.57%12.36M	-57.57%12.36M	-10.90%24.25M	0.10%27.73M
Free cash flow	-16.15%-2.31M	4.36%-6.21M	-23.60%-1.97M	-3.51%-1.45M	65.00%-807K	-66.08%-1.99M	-31.47%-6.49M	-52.44%-1.59M	5.74%-1.4M	-85.67%-2.31M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall